Top Page
Sumitomo Seika Chemicals Co., Ltd.
(4008)
Sumitomo Seika Chemicals Co., Ltd. (4008) vs. iShares MSCI Japan ETF (EWJ)
Sumitomo Seika Chemicals Co., Ltd. Business Overview & Revenue Model
Sumitomo Seika Chemicals Co., Ltd. Financial Statement Overview
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.24B | 147.57B | 142.99B | 143.04B | 115.58B | 103.25B |
| Gross Profit | 30.38B | 30.68B | 28.01B | 30.14B | 26.15B | 25.18B |
| EBITDA | 10.96B | 14.35B | 14.87B | 15.55B | 13.59B | 15.38B |
| Net Income | 4.49B | 5.96B | 6.17B | 8.59B | 5.89B | 7.12B |
Balance Sheet | ||||||
| Total Assets | 141.32B | 141.53B | 136.31B | 126.65B | 121.27B | 107.83B |
| Cash, Cash Equivalents and Short-Term Investments | 18.93B | 16.86B | 21.66B | 23.55B | 29.25B | 25.66B |
| Total Debt | 22.29B | 18.86B | 11.57B | 12.62B | 14.55B | 14.09B |
| Total Liabilities | 47.05B | 47.22B | 41.25B | 39.99B | 39.37B | 32.34B |
| Stockholders Equity | 94.26B | 94.31B | 95.05B | 86.66B | 78.73B | 72.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.98B | 2.04B | -128.00M | 5.39B | 13.18B |
| Operating Cash Flow | 0.00 | 13.68B | 12.01B | 6.70B | 9.02B | 16.25B |
| Investing Cash Flow | 0.00 | -20.91B | -10.37B | -5.94B | -4.32B | -2.23B |
| Financing Cash Flow | 0.00 | 3.19B | -5.77B | -8.30B | -2.99B | -3.26B |
Sumitomo Seika Chemicals Co., Ltd. Technical Analysis
Sumitomo Seika Chemicals Co., Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥309.87B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
70 Outperform | ¥92.81B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
67 Neutral | ¥794.79B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥285.15B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
65 Neutral | ¥253.65B | 6.13 | 1.47% | 4.29% | -7.45% | -71.68% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥801.31B | 12.79 | 2.01% | 3.82% | -4.63% | -65.11% |
Sumitomo Seika Chemicals Co., Ltd. Corporate Events
Sumitomo Seika Chemicals has reported the latest progress of its share buyback program authorized by its board in November 2025. Between February 1 and February 28, 2026, the company repurchased 35,100 of its own common shares on the Tokyo Stock Exchange at a total cost of ¥221.45 million.
Under the broader authorization, the company may acquire up to 210,000 shares or ¥1 billion of stock during the period from November 13, 2025, to March 31, 2026. As of February 28, 2026, cumulative repurchases reached 142,800 shares for about ¥795.07 million, signaling a substantial execution of the buyback that is likely to support shareholder returns and capital efficiency metrics.
The most recent analyst rating on (JP:4008) stock is a Buy with a Yen7681.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals will implement a five-for-one share split of its common stock, effective April 1, 2026, aiming to lower the investment unit price, enhance stock liquidity, and broaden its shareholder base. The move will increase issued shares from about 14 million to nearly 70 million, and authorized shares to 200 million, coupled with amendments to its Articles of Incorporation and an adjusted shareholder benefits scheme that preserves the economic value of rewards but raises the minimum holding requirement from 100 to 500 shares, aligning incentives with the new share structure without diluting existing benefits.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5754.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals reported nine-month consolidated net sales of ¥111.7 billion, down slightly year on year, while operating profit rose 18.7% to ¥10.3 billion and ordinary profit increased 9.3%. Profit attributable to owners of the parent fell 27.8% to ¥5.0 billion, with basic earnings per share declining to ¥380.51, even as comprehensive income improved.
The company’s financial position remained solid, with total assets of ¥150.6 billion and an equity ratio of 66.4% as of December 31, 2025. It revised its full-year forecast, now targeting marginally higher net sales of ¥148.0 billion and a 40% jump in operating profit to ¥15.0 billion, and lifted its year-end dividend forecast, signaling confidence in earnings recovery and shareholder returns despite current profit pressure.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5754.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals has raised its full-year consolidated forecast for the fiscal year ending March 31, 2026, citing a weaker yen, lower raw material and fuel costs, and higher sales volumes of water-soluble polymers. The company now expects net sales of ¥148 billion and profit attributable to owners of the parent of ¥7 billion, both above previous guidance and last year’s levels, implying a substantial improvement in profitability.
Reflecting the stronger outlook, the board also approved an increase in the year-end dividend forecast from ¥100 to ¥120 per share, lifting the projected annual dividend for FY2025 to ¥220 per share including the interim payout. This move underscores management’s confidence in earnings momentum and signals enhanced returns for shareholders, supported by favorable currency trends and operational gains at overseas manufacturing sites.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5754.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals will book an extraordinary loss in the third quarter of the fiscal year ending March 31, 2026, stemming from a previously disclosed case of product price mischarging at one of its subsidiaries. After continued negotiations, the company has set aside a 3,209 million yen provision to compensate a customer for lost profits, building on an earlier 1,284 million yen extraordinary loss recognized in the second quarter.
The new provision reflects progress toward a mutually acceptable settlement, signaling that the dispute is moving toward resolution while crystallizing the financial cost of the misconduct. Management has already factored the impact into its most recent earnings forecasts, suggesting that investors and other stakeholders should not expect additional surprise charges from this issue under current assumptions.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5754.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals has disclosed the latest status of its ongoing share buyback program authorized by its board in November 2025. Between January 1 and January 31, 2026, the company repurchased 43,300 shares of its common stock for a total of 232.63 million yen through market purchases on the Tokyo Stock Exchange, bringing cumulative acquisitions under the current mandate to 107,700 shares at a cost of 573.619 million yen. This activity represents a partial execution of the approved buyback framework, which allows up to 210,000 shares or 1 billion yen in purchases through March 31, 2026, and underscores management’s continued capital allocation to shareholder returns, potentially supporting earnings per share and the company’s market valuation.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5628.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals Co., Ltd. has announced that Independent External Director and Audit and Supervisory Committee member Fujio Yoshiike has resigned from the Board as of January 30, 2026, due to health reasons. The company stated that, despite this departure, it continues to meet the legally and statutorily required number of Audit and Supervisory Committee members, and that its Board of Directors will still have one-third of seats occupied by independent directors, indicating that its governance structure and compliance framework remain intact following the change.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5681.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals has reported on the progress of its board-approved share buyback program, authorized in November 2025 under the Companies Act and its Articles of Incorporation. Between December 1 and December 31, 2025, the company repurchased 39,100 shares of its common stock for a total of ¥207,073,000 through market purchases on the Tokyo Stock Exchange, bringing cumulative acquisitions under the program as of December 31 to 64,400 shares at a cost of ¥340,989,000. This remains within the previously set ceiling of up to 210,000 shares and ¥1 billion through March 31, 2026, indicating continued capacity to buy back additional shares and signaling ongoing efforts to manage its capital structure and potentially enhance shareholder returns.
The most recent analyst rating on (JP:4008) stock is a Hold with a Yen5810.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.